Temporal trends in clinical characteristics, management and prognosis of patients with symptomatic heart failure in japan “ Report from the CHART studies

Circulation Journal

Volumn 79, Issue 11, 2015, Pages 2396-2407

  Ushigome, Ryoichi ^a   Sakata, Yasuhiko ^a   Nochioka, Kotaro ^a   Miyata, Satoshi ^a   Miura, Masanobu ^a   Tadaki, Soichiro ^a   Yamauchi, Takeshi ^a   Sato, Kenjiro ^a   Onose, Takeo ^a   Tsuji, Kanako ^a   Abe, Ruri ^a   Oikawa, Takuya ^a   Kasahara, Shintaro ^a   Takahashi, Jun ^a   Shimokawa, Hiroaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Beta blocker; Prognosis; Statin; Symptomatic heart failure

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; NITROGEN; UREA; CARDIOVASCULAR AGENT;

ACUTE HEART INFARCTION; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CAUSE OF DEATH; CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HUMAN; JAPAN; LENGTH OF STAY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PROGNOSIS; SYMPTOMATIC HEART FAILURE; CLINICAL TRIAL; COMORBIDITY; DRUG EFFECTS; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; INCIDENCE; KAPLAN MEIER METHOD; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PREVALENCE; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

AGED; CARDIOVASCULAR AGENTS; COMORBIDITY; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; PREVALENCE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84944738803     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-15-0514     Document Type: Article

References (37)

1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2015 update: A Report from the American Heart Association. Circulation 2015; 131: e29-e322, doi:10.1161/CIR.0000000000000152
2. Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, et al. The global health and economic burden of hospitalizations for heart failure: Lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 2014; 63: 1123-1133
3. Sakata Y, Shimokawa H. Epidemiology of heart failure in Asia. Circ J 2013; 77: 2209-2217
4. Shimokawa H, Miura M, Nochioka K, Sakata Y. Heart failure as a general pandemic in Asia. Eur J Heart Fail 2015; 17: 884-892
5. Okura Y, Ramadan MM, Ohno Y, Mitsuma W, Tanaka K, Ito M, et al. Impending epidemic future projection of heart failure in Japan to the year 2055. Circ J 2008; 72: 489-491
6. e-Stat. Portal Site of Official Statics of Japan. https://e-stat.go.jp (accessed May10, 2015).
7. Shiba N, Watanabe J, Shinozaki T, Koseki Y, Sakuma M, Kagaya Y, et al. Analysis of chronic heart failure registry in the Tohoku District: Third year follow-up. Circ J 2004; 68: 427-434
8. Shiba N, Nochioka K, Miura M, Kohno H, Shimokawa H; CHART-2 Investigators. Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan: First report from the CHART-2 Study. Circ J 2011; 75: 823-833
9. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/ AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013; 128: e240-e327, doi:10.1161/CIR.0b013e31829e8776
10. McKee PA, Castelli WP, McNamara PM, Kannel WB. Natural history of congestive heart failure: The Framingham Study. N Engl J Med 1971; 285: 1441-1446
11. JCS Joint Working Group. Guidelines for management of dilated cardiomyopathy and secondary cardiomyopathy (JCS2011). http://www.j-circ.or.jp/guideline/pdf/JCS2011_tomoike_h.pdf (accessed May10, 2015).
12. JCS Joint Working Group. Guidelines for diagnosis and treatment of patients with hypertrophic cardiomyopathy (JCS 2012). http://www.j-circ.or.jp/guideline/pdf/JCS2012_doi_h.pdf (accessed May 10, 2015).
13. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: Prevalence and mortality in a population- based cohort. J Am Coll Cardiol 1999; 33: 1948-1955
14. Nochioka K, Sakata Y, Miyata S, Miura M, Takada T, Tadaki S, et al. Prognostic impact of statin use in patients with heart failure and preserved ejection fraction. Circ J 2015; 79: 574-582
15. Tsutsui H, Tsuchihashi-Makaya M, Kinugwa S, Goto D, Takeshita A. Characteristics and outcomes of patients with heart failure in general practices and hospitals: Japanese Cardiac Registry of Heart Failure in General Practice (JCARE-GENERAL). Circ J 2007; 71: 449-454
16. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88: 107-115
17. Adams KF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005; 149: 209-216
18. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, et al. Euro Heart Failure Survey II (EHFS II): A survey on hospitalized acute heart failure patients: Description of population. Eur Heart J 2006; 27: 2725-2736
19. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251-259
20. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, et al. Outcome of heart failure with preserved ejection fraction in a population- based study. N Engl J Med 2006; 355: 260-269
21. Steinberg BA, Zhao X, Heidenreich PA, Peterson ED, Bhatt DL, Cannon CP, et al. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction prevalence, therapies, and outcomes. Circulation 2012; 126: 65-75
22. Douglas PS, Brennan JM, Anstrom KJ, Sedrakyan A, Eisenstein EL, Haque G, et al. Clinical effectiveness of coronary stents in elderly persons: Results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data Registry. J Am Coll Cardiol 2009; 53: 1629-1641
23. Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, et al. Safety and efficacy of drug-eluting and bare metal stents: Comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009; 119: 3198-3206
24. Hannan EL, Samadashvili Z, Cozzens K, Walford G, Jacobs AK, Holmes DR, et al. Comparative outcomes for patients who do and do not undergo percutaneous coronary intervention for stable coronary artery disease in New York. Circulation 2012; 125: 1870-1879
25. Zellweger MJ, Kaiser C, Jeger R, Brunner-La Rocca HP, Buser P, Bader F, et al. Coronary artery disease progression late after successful stent implantation. J Am Coll Cardiol 2012; 59: 793-799
26. Ushigome R, Sakata Y, Nochioka K, Miyata S, Miura M, Tadaki S, et al. Long-term prognosis of dilated cardiomyopathy with implementation of evidenced-based medication: Report from the CHART Studies. Circ J 2015; 79: 1332-1341
27. CIBIS-II Investigators and Committees. The Cardiac Insufficiency BISoprolol study II (CIBIS-II): A randomised trial. Lancet 1999; 352: 9-13
28. Kober L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995; 80: 257-266
29. Pitt B, Segal R, Martinez FA, Meurers G, Cowley A, Thomas I, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997; 349: 747-752
30. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709-717
31. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347: 1397-1402
32. Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): A randomised placebo-controlled study. Lancet 2010; 376: 875-885
33. Satake H, Fukuda K, Sakata Y, Miyata S, Nakano M, Kondo M, et al. Current status of primary prevention of sudden cardiac death with implantable cardioverter defibrillator in patients with chronic heart failure: A report from the CHART-2 Study. Circ J 2015; 79: 381-390
34. JCS Joint Working Group. Guidelines for non-pharmacotherapy of cardiac arrhythmias (JCS 2011): Digest version. Circ J 2013; 77: 249-274
35. Hamaguchi S, Kinugawa S, Sobirin MA, Goto D, Tsuchihashi- Makaya M, Yamada S, et al. Mode of death in patients with heart failure and reduced vs. preserved ejection fraction: Report from the registry of hospitalized heart failure patients. Circ J 2012; 76: 1662-1669
36. Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005; 353: 2581-2588
37. Hoang A, Shen C, Zheng J, Taylor S, Groh WJ, Rosenman M, et al. Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: A 2012 calculation for a midwestern health referral region. Heart Rhythm 2014; 11: 849-855.